SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-037189
Filing Date
2023-03-27
Accepted
2023-03-27 17:17:29
Documents
14
Period of Report
2023-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310615d1_8k.htm   iXBRL 8-K 35938
2 EXHIBIT 4.1 tm2310615d1_ex4-1.htm EX-4.1 64852
3 EXHIBIT 10.1 tm2310615d1_ex10-1.htm EX-10.1 82093
  Complete submission text file 0001104659-23-037189.txt   401117

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mist-20230321.xsd EX-101.SCH 3055
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20230321_lab.xml EX-101.LAB 34477
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20230321_pre.xml EX-101.PRE 22610
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310615d1_8k_htm.xml XML 3875
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 23765406
SIC: 2834 Pharmaceutical Preparations